KPTI - Karyopharm Therapeutics EPS misses by $0.08 beats on revenue February, 13 2020 07:07 AM Karyopharm Therapeutics Inc. Karyopharm Therapeutics (NASDAQ:KPTI): Q4 GAAP EPS of -$0.76 misses by $0.08.More news on: Karyopharm Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...